You are here

Inspiratory Impedance as a Treatment for Traumatic Brain Injury

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-07-C-0018
Agency Tracking Number: A062-150-0842
Amount: $119,673.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: A06-150
Solicitation Number: 2006.2
Timeline
Solicitation Year: 2006
Award Year: 2006
Award Start Date (Proposal Award Date): 2006-11-07
Award End Date (Contract End Date): 2007-09-06
Small Business Information
7615 Golden Triangle Drive Suite A
Eden Prairie, MN 55344
United States
DUNS: 140320396
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Keith Lurie
 Chief Medical Officer
 (612) 986-3917
 klurie@advancedcirculatory.com
Business Contact
 Anja Metzger
Title: Director of Research & Grants Mgmt
Phone: (651) 226-1626
Email: ametzger@advancedcirculatory.com
Research Institution
N/A
Abstract

Traumatic head and neck injuries account for 16-33% of all war-related injuries and are a leading cause of mortality upon evacuation to a definitive care setting. This application is focused on treating one of the most important determinants of outcome from severe head injury, the degree and duration of elevated intracranial pressure (ICP). The main objective of this proposal is to continue the development of the inspiratory impedance threshold device (ITD); an operationally useful and effective device initially designed to counteract the effects of severe hypotension after the development of hemorrhagic shock, heat shock, and dehydration. New research has discovered that the ITD has a marked effect on reducing ICP. When ICPs are decreased in spontaneously breathing patients during inspiration through an ITD or when using a modified ITD called an intrathoracic pressure regulator (ITPR) in non-breathing patients, the small vacuum created in the thorax enhances venous return to the heart thereby enhancing cardiac output and decreasing ICP. The successful development and deployment of a new device designed to immediately decrease elevated ICP or prevent the onset of elevated ICP following traumatic brain injury is an important advance in treating battlefield casualties, a major cause of death for American soldiers.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government